A comparison of apremilast monotherapy and combination therapy for psoriatic arthritis in a real-life setting: Data from the Leeds Combined Psoriatic Service
Open Access
- 1 June 2019
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 80 (6) , 1796-1798
Abstract
No abstract availableFunding Information
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
This publication has 4 references indexed in Scilit:
- Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective studyJournal of the American Academy of Dermatology, 2018
- A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective studyJournal of the American Academy of Dermatology, 2018
- Apremilast for the treatment of active psoriatic arthritis: a single-centre real-life experienceRheumatology, 2017
- Apremilast: A Review in Psoriasis and Psoriatic ArthritisDrugs, 2017